Abstract
Normal human T lymphocytes incubated with adenosine (10 muM) for 30 min at 37 degrees C show an increase in the percentage of cells expressing receptors for the Fc portion of IgG (RFc(gamma)) and the OKT8 antigen, while the proportion of OKT4(+) cells decreases. These effects occur exclusively in a subset of T cells with theophylline-resistant sheep erythrocyte receptors (T(R) cells) that is enriched for OKT4(+) cells. Untreated normal T(R) cells express helper/inducer cell activity for T-cell-dependent B-cell differentiation, while adenosine-treated T(R) cells suppress B-cell differentiation. In contrast, in T(R) cells isolated from patients with systemic lupus erythematosus (SLE), adenosine fails to induce immunosuppressor activity or to increase the percentage of OKT8(+) and RFc(gamma) (+) cells. In addition, although incubation of normal T(R) cells with adenosine causes a transient increase in cAMP levels (up to 160% of control within 5 min), in SLE T(R) cells, cAMP levels fall by 50% within 10 min. The photoaffinity label 8-azidoadenosine cyclic [(32)P]monophosphate has been used to show that human T lymphocytes have a single cAMP receptor site that appears to be the regulatory subunit of type I protein kinase. In normal T(R) cells, this receptor becomes occupied in response to adenosine. In contrast, in SLE T(R) cells, no change in cAMP receptor occupancy is detected. Although adenosine has a differential effect on normal and SLE T(R) cells, cAMP derivatives that can traverse the cell membrane (8-bromo- and 8-azidoadenosine cyclic monophosphates) induce an increase in the RFc(gamma) (+) cell subset in both normal and SLE T(R) cells. These results suggest that cAMP mediates the effects of adenosine on cell surface markers of T lymphocytes. The lack of an adenosine receptor-coupled adenylate cyclase activity in SLE T(R) cells may account, in part, for their lack of immunosuppressive activity.
MeSH Terms
Adenosine/pharmacology
Antigens, Surface/analysis
Cyclic AMP/metabolism
Drug Resistance
Humans
Immune Tolerance/drug effects
Lupus Erythematosus, Systemic/immunology
Molecular Weight
Receptors, Cell Surface/immunology
Receptors, Cyclic AMP/analysis
Receptors, Fc/analysis
Receptors, Purinergic
T-Lymphocytes/immunology
T-Lymphocytes, Helper-Inducer/drug effects
Theophylline/pharmacology
Chemicals
Antigens, Surface
Receptors, Cell Surface
Receptors, Cyclic AMP
Receptors, Fc
Receptors, Purinergic
Theophylline
Cyclic AMP
Adenosine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Mandler R
Birch R E
Polmar S H
Kammer G M
Rudolph S A
References (17)
17 references, click to expand
-
Cyclic nucleotide-dependent protein kinases. IV. Widespread occurrence of adenosine 3',5'-monophosphate-dependent protein kinase in various tissues and phyla of the animal kingdom.
Proc Natl Acad Sci U S A. 1969 Dec;64(4):1349-55
PMID: 4393915
-
Cytochemical identification of monocytes and granulocytes.
Am J Clin Pathol. 1971 Mar;55(3):283-90
PMID: 5549896
-
A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate.
Biochem J. 1971 Feb;121(3):561-2
PMID: 4330379
-
Protein kinases.
Curr Top Cell Regul. 1972;5:99-133
PMID: 4358204
-
Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.
J Exp Med. 1977 Jul 1;146(1):184-200
PMID: 301544
-
Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.
J Clin Invest. 1978 Oct;62(4):789-96
PMID: 308952
-
Immunoregulatory aberrations in systemic lupus erythematosus.
J Immunol. 1978 Oct;121(4):1473-9
PMID: 359708
-
Theophylline modulation of E-rosette formation: an indicator of T-cell maturation.
Clin Exp Immunol. 1978 Sep;33(3):503-13
PMID: 310744
-
Endogenous protein phosphorylation and dephosphorylation.
Adv Cyclic Nucleotide Res. 1979;10:107-33
PMID: 222121
-
Regulation of adenylate cyclase by adenosine.
Mol Cell Biochem. 1979 Jun 15;25(3):143-69
PMID: 225658
-
Suppression of immunoglobulin production in normal human B lymphocytes by two T-cell subsets distinguished following in vitro treatment with adenosine.
Clin Immunol Immunopathol. 1980 Jan;15(1):44-51
PMID: 6444561
-
Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists.
Can J Physiol Pharmacol. 1980 Jun;58(6):673-91
PMID: 6253037
-
Induction of Fc gamma receptors on a subpopulation of human T lymphocytes by adenosine and impromidine, an H2-histamine agonist.
Cell Immunol. 1981 Jan 15;57(2):455-67
PMID: 6260385
-
Pharmacological modification of immunoregulatory T lymphocytes. I. Effect of adenosine, H1 and H2 histamine agonists upon T lymphocyte regulation of B lymphocyte differentiation in vitro.
Clin Exp Immunol. 1982 Apr;48(1):218-30
PMID: 6211316
-
Pharmacological modification of immunoregulatory T lymphocytes . II. Modulation of T lymphocyte cell surface characteristics.
Clin Exp Immunol. 1982 Apr;48(1):231-8
PMID: 6177462
-
Cyclic AMP receptors and cation fluxes in the turkey erythrocyte.
Mol Pharmacol. 1982 Mar;21(2):503-10
PMID: 7099149
-
Photoaffinity labeling of a protein kinase from bovine brain with 8-azidoadenosine 3',5'-monophosphate.
Biochemistry. 1975 Aug 26;14(17):3858-62
PMID: 169888